Brief: Abionyx Announces Positive Clinical Findings For CER-001 In Treating Covid-19

Abionyx Pharma SA

24/03/2022 17:45

March 24 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX ANNOUNCES POSITIVE CLINICAL FINDINGS FOR CER-001
IN
TREATING COVID-19, PUBLISHED IN BIOMEDECINES, DEMONSTRATING THAT
CER-001 LIMITS INFLAMMATION EFFECTS
    * RESULTS SUGGEST RECOMBINANT HDL INFUSIONS ARE A POTENTIAL
THERAPEUTIC STRATEGY TO BE EXPLORED IN COVID-19 PATIENTS
    * ABIONYX PHARMA IS AWAITING FURTHER RESULTS FROM ONGOING
CLINICAL
STUDIES IN INFLAMMATORY CONDITIONS

Source text for Eikon:  ID:nBwbg3Kh3a 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))